RCAS1 decidual immunoreactivity during placental abruption: Immune cell presence and activity

American Journal of Reproductive Immunology

Volumn 58, Issue 1, 2007, Pages 46-55

  Wicherek, Lukasz ^a   Galazka, Krystyna ^a   Lazar, Agata ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Decidua; Immune tolerance; Placental abruption; RCAS1; Retained placental tissue

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; RCAS1 ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL ACTIVITY; CELL COUNT; CONTROLLED STUDY; DECIDUA; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE STATUS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETAINED PLACENTA; SOLUTIO PLACENTAE; STATISTICAL SIGNIFICANCE;

ABRUPTIO PLACENTAE; ANTIGENS, NEOPLASM; DECIDUA; FEMALE; HUMANS; IMMUNE SYSTEM; PLACENTA, RETAINED; PREGNANCY;

EID: 34250663941     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00490.x     Document Type: Article

References (51)

1. Ananth CV, Oyelese Y, Prasad V, Getahun D, Smulian JC: Evidence of placental abruption as a chronic process: Associations with vaginal bleeding early in pregnancy and placental lesions. Eur J Obstet Gynecol Reprod Biol 2006; 128: 15-21.
2. Ananth CV, Wilcox AJ: Placental abruption and perinatal mortality in the United States. Am J Epidemiol 2001; 153: 332-337.
3. Ngeh N, Bhide A: Antepartum haemorrhage. Curr Obstet Gynecol 2006; 16: 79-83.
4. Ananth CV, Oyelese Y, Yeo L, Pradhan A, Vintzileos AM: Placental abruption in the United States, 1979 through 2001: Temporal trends and potential determinants. Am J Obstet Gynecol 2005; 192: 191-198.
5. Lindqvist PG, Happach C: Risk and risk estimation of placenta abruption. Eur J Obstet Gynecol Reprod Biol 2006; 126: 160-164.
6. Hemminki E, Merilainen J: Long-term effects of cesarean sections: ectopic pregnancies and placental problems. Am J Obstet Gynecol 1996; 174: 1569-1574.
7. Ananth CV, Oyelese Y, Srinivas N, Yeo L, Vintzileos AM: Preterm premature rupture of membrane, intrauterine infection, and oligohydramions: Risk factors for placental abruption. Obstet Gynecol 2004; 104: 71-77.
8. Getahun D, Oyelese Y, Salihu HM, Ananth VC: Previous cesarean delivery and risk of palcenta previa and placental abruption. Obstet Gynecol 2006; 107: 771-778.
9. Thomson AJ, Telfer JF, Young A, Campbell S, Stewart CJ, Cameron IT, Greer IA, Norman JE: Leukocytes infiltrate the myometrium during human parturition: Further evidence that labour is an inflammatory process. Hum Reprod 1999; 14: 229-236.
10. Delgado I, Neubert R, Dudenhausen JW: Changes in white blood cells during parturition in mothers and newborn. Gynecol Obstet Invest 1994; 38: 227-235.
11. Szekeres-Bartho J, Varga P, Pacsa AS: Immunologic factors contributing to the initiation of labor -lymphocyte reactivity in term labor and threatened preterm delivery. Am J Obstet Gynecol 1986; 155: 108-112.
12. Abadia-Molina AC, Ruiz C, Montes MJ, King A, Loke YW, Olivares EG: Immune phenotype and cytotoxic activity of lymphocytes from human term decidua against trophoblast. J Reprod Immunol 1996; 31: 109-123.
13. Osman I, Young A, Ledingham MA, Thomson AJ, Jordan F, Greer IA, Norman JE: Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod 2003; 9: 41-45.
14. Wicherek L, Klimek M, Dutsch-Wicherek M, Kolodziejski L, Skotniczny K: The molecular changes during placenta detachment. Eur J Obstet Gynecol Reprod Biol 2006; 125: 171-175.
15. Sindram-Trujillo A, Scherjon S, Kanhai H, Roelen D, Class F: Increased T-cell activation in decidua parietalis compared to decidua basalis in uncomplicated human term pregnancy. Am J Reprod Immunol 2003; 49: 261-268.
16. Sindram-Trujillo AP, Scherjon SA, van Hulst-van Miert PP, Kanhai HH, Roelen DL, Claas FH: Comparison of decidual leukocytes following spontaneous vaginal delivery and elective cesarean section in uncomplicated human term pregnancy. J Reprod Immunol 2004; 62: 125-137.
17. Qiu Q, Yang M, Tsang BK, Gruslin A: Fas ligand expression by maternal decidual cells is negatively correlated with the abundance of leukocytes present at the maternal -fetal interface. J Reprod Immunol 2005; 65: 121-132.
18. Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999; 5: 938-942.
19. Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S, Sakai K, Nakashima M, Watanabe T, Nakano H: The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium. Gynecol Oncol 2000; 79: 424-429.
20. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer. Gynecol Oncol 2005; 97: 772-779.
21. Kawano Y, Kaku T, Sonoda K, Hirakawa T, Kobayashi H, Ohishi Y, Nakano H: Expression of RCAS1 in female genital organs. Int J Gynecol Pathol 2005; 24: 330-334.
22. Wicherek L, Popiela TJ, Galazka K, Dutsch-Wicherek M, Oplawski M, Basta A, Klimek M: Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and the endometrium according to menstrual cycle changes. Gynecol Oncol 2005; 99: 622-630.
23. Ohshima K, Nakashima M, Sonoda K, Kikuchi M, Watanabe T: Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: The possible role in immune privilege. Clin Exp Immunol 2001; 123: 481-486.
24. Clark DA, Flanders KC, Banwatt D, Millar-Book W, Manuel J, Stedronska-Clark J, Rowley B: Murine pregnancy decidua produces a unique immunosuppressive molecule related to transforming growth factor beta-2. J Immunol 1990; 144: 3008-3014.
25. Wicherek L, Dutsch-Wicherek M, Galazka K, Banas T, Popiela T, Lazar A, Kleinrok-Podsiadlo B: Comparison of RCAS1 and metallothionein expression and the presence and activity of immune cells in human ovarian and abdominal wall endometriomas. Reprod Biol Endocrinol 2006; 4: 41.
26. Wicherek L, Klimek M, Galazka K: Cycle dependent RCAS1 expression with respect to the immune cells presence and activity. Neuro Endocrinol Lett 2006; 27: 645-650.
27. Campbell JJ, Qin S, Unutmaz D, Soler D, Murphy KE, Hodge MR, Wu L, Butcher EC: Unique subpopulations of CD56+NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001; 166: 6477-6482.
28. Osmers RG, Blaser J, Kuhn W: Interleukin-8 synthesis at the onset of labor. Obstet Gynecol 1995; 86: 223-228.
29. Chao KH, Wu MY, Yang JH, Chen SU, Yang YS, Ho HN: Expression of the interleukin-2 receptor alfa (CD25) is selectively decreased on decidual CD4+ and CD8+ T lymphocytes in normal pregnancies. Mol Hum Reprod 2002; 8: 667-673.
30. Ho HN, Chao KH, Chen CK, Yang YS, Huang SC: Activation status of T and NK cells in the the endometrium throughout menstrual cycle and normal and abnormal early pregnancy. Hum Immunol 1996; 49: 130-136.
31. Oyelese Y, Ananth CV: Placental abruption. Obstet Gynecol 2006; 108: 1005-1016.
32. Dommisse J, Tiltman AJ: Placental bed biopsies in placental abruption. Br J Obstet Gynaecol 1992; 99: 651-654.
33. Kim KR, Jun SY, Kim JY, Ro JY: Implantation site intermediate trophoblast in placenta cretas. Mod Pathol 2004; 17: 1483-1490.
34. Biswas R, Sawhney H, Dass R, Saran R, Vasishta K: Histopathological study of placental bed biopsy in placenta previa. Acta Obstet Gynecol Scand 1999; 78: 173-179.
35. Kelehan P, Mooney EE: Pathology of the uterus. In Postpartum Hemorrhage. C B-Lynch, LG Keith, AB Lalonde, M Karoshi (eds). Duncow, Kirkmahoe, Dumfriesshire, Sapiens Publishing, 2006, pp 326-338.
36. Bachmayer N, Rafik-Hamad R, Liszka L, Bremme K, Sverremark-Ekstrom E: Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the NK-cell promoting cytokine interleukin-12 in pre-eclampsia. Am J Reprod Immunol 2005; 56: 292-301.
37. Azizieh F, Raghupathy R, Makhseed M: Maternal cytokine production patterns in women with pre-eclampsia. Am J Reprod Immunol 2005; 54: 30-37.
38. Steinborn A, Rebmann V, Scharf A, Sohn C, Grosse-Wilde H: Soluble HLA-DR levels in the maternal circulation of normal and pathologic pregnancy. Am J Obstet Gynecol 2003; 188: 473-479.
39. Bulmer JN, Lash GE: Human uterAne natural killer cells: a reappraisal. Mol Immunol 2005; 42: 511-521.
40. Von Rango U, Krusche CA, Kertschanska S, Alfer J, Kaufmann P, Beier HM: Apoptosis of extravillous trophoblast cells limits the trophoblast invasion in uterine but not in tubal pregnancy during first trimester. Placenta 2003; 24: 929-940.
41. Steinborn A, Sohn C, Sayehli C, Baudendistel A, Huwelmeier D, Solbach C, Schmitt E, Kaufmann M: Spontaneous labour at term is associated with fetal monocyte activation. Clin Exp Immunol 1999; 117: 147-152.
42. Wicherek L, Dutsch-Wicherek M, Mak P, Klimek M: The role of RCAS1 and oxytocinase in immune tolerance during pregnancy. Fetal Diagn Ther 2005; 20: 420-425.
43. Balkundi DR, Hanna N, Hileb M, Dougherty J, Sharma S: Labor-associated changes in Fas Ligand expression and function in human placenta. Pediatr Res 2000; 7: 301-308.
44. Hackmon R, Hallak M, Krup M, Weitzman D, Sheiner E, Kaplan B, Weinstein Y: HLA-G antigen and partMrition: maternal serum, fetal serum and amniotic fluid levels during pregnancy. Fetal Diagn Ther 2005; 19: 404-409.
45. Fournel S, Aguerre-Girr M, Huc X, Lenfant F, Alam A, Toubert A, BensussaS A, Le Bouteiller P: Cutting edge: soluble HLA-G1 triggers CD95/ CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000; 164: 6100-6104.
46. Ordi J, Casals G, Ferrer B, Creus M, Guix C, Palacin A, Campo E, Balasch J: Uterine (CD56+) natural killer cells recrAitment: association with decidual reaction rather than embryo implantation. Am J Reprod Immunol 2006; 55: 369-377.
47. Steinborn A, Rebmann V, Scharf A, Sohn C, Grosse-Wilde H: Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G. J Clin Immunol 2003; 23: 307-314.
48. Steinborn A, Seidl C, Sayehli C, Sohn C, Seifried E, Kaufmann M, Schmitt E: Anti-fetal immune response mechanisms may be involved in the pathogenesis of placental abruption. Clin Immunol 2004; 110: 45-54.
49. Wicherek L, Klimek M, Czekierdowski A, Galazka K, Zabinska-Popiela M, Czekierdowska S, Popiela TJ, Dutsch-Wicherek M: Evidence for changes in RCAS1 expression in maternal immune response during uterine cervix ripening. Pol J Environ Stud 2005; 14 (Suppl. 2): 391-395.
50. Vassiliadou N, Bulmer JN: Characterization of tubal and decidual leukocyte populations in ectopic pregnancy: Evidence that endometrial granulated lymphocytes are absent from tubal implantation site. Fertil Steril 1998; 69: 760-767.
51. Von Rango U, Classen-Linke I, Kertschanska S, Kemp B, Beier HM: Effects of trophoblast invasion on the distribution of leukocytes in uterine and tubal implantation site. Fertil Steril 2001; 76: 116-124.